AIMS: The number of prescription medications and out-of-pocket expenses of individuals with type 2 diabetes mellitus (T2DM) were evaluated to assess the economic burden of diabetes. METHODS: The self-reported number of prescription medications and out-of-pocket healthcare expenses were evaluated from respondents of the United States SHIELD study with and without a diagnosis of T2DM. Medications included monotherapy and combination therapy; combination tablets were counted as one agent. Analysis of variance and multivariate linear regression models adjusted for age, gender, prescription insurance coverage, and household income. RESULTS: Of the T2DM respondents (n=3551), 40% were on 1 prescription antidiabetic agent (7% insulin alone), 26% were on 2 agents, 8% were on >or=3 agents, with a mean of 1.3 antidiabetic agents. After adjusting for age, gender, insurance coverage, and income, respondents with T2DM had a significantly larger total number of prescriptions (6.2) and higher out-of-pocket expenses for both annual medical ($1158) and monthly prescription ($144) expenses, compared with respondents without T2DM (n=8686) (4.1 prescriptions, $925 annual medical, $118 monthly prescription) (p<0.01). CONCLUSIONS: Increased out-of-pocket medical and medication costs in T2DM are due to the use of both antidiabetic agents and other medications for treatment of comorbid conditions.
AIMS: The number of prescription medications and out-of-pocket expenses of individuals with type 2 diabetes mellitus (T2DM) were evaluated to assess the economic burden of diabetes. METHODS: The self-reported number of prescription medications and out-of-pocket healthcare expenses were evaluated from respondents of the United States SHIELD study with and without a diagnosis of T2DM. Medications included monotherapy and combination therapy; combination tablets were counted as one agent. Analysis of variance and multivariate linear regression models adjusted for age, gender, prescription insurance coverage, and household income. RESULTS: Of the T2DM respondents (n=3551), 40% were on 1 prescription antidiabetic agent (7% insulin alone), 26% were on 2 agents, 8% were on >or=3 agents, with a mean of 1.3 antidiabetic agents. After adjusting for age, gender, insurance coverage, and income, respondents with T2DM had a significantly larger total number of prescriptions (6.2) and higher out-of-pocket expenses for both annual medical ($1158) and monthly prescription ($144) expenses, compared with respondents without T2DM (n=8686) (4.1 prescriptions, $925 annual medical, $118 monthly prescription) (p<0.01). CONCLUSIONS: Increased out-of-pocket medical and medication costs in T2DM are due to the use of both antidiabetic agents and other medications for treatment of comorbid conditions.
Authors: Julie A Schmittdiel; Jay Desai; Emily B Schroeder; Andrea R Paolino; Gregory A Nichols; Jean M Lawrence; Patrick J O'Connor; Kris A Ohnsorg; Katherine M Newton; John F Steiner Journal: Healthc (Amst) Date: 2015-03-13
Authors: Julie A Schmittdiel; Marsha A Raebel; Wendy Dyer; Stanley Xu; Glenn K Goodrich; Emily B Schroeder; Jodi B Segal; Patrick J O' Connor; Gregory A Nichols; Jean M Lawrence; H Lester Kirchner; Andy J Karter; Jennifer Elston Lafata; Melissa G Butler; John F Steiner Journal: J Am Pharm Assoc (2003) Date: 2014 Jul-Aug
Authors: Julie A Schmittdiel; Anjali Gopalan; Mark W Lin; Somalee Banerjee; Christopher V Chau; Alyce S Adams Journal: Curr Diab Rep Date: 2017-05 Impact factor: 4.810
Authors: Julie A Schmittdiel; Solveig A Cunningham; Sara R Adams; Jannie Nielsen; Mohammed K Ali Journal: Ann Fam Med Date: 2018-07 Impact factor: 5.166
Authors: Adem Sav; Michelle A King; Jennifer A Whitty; Elizabeth Kendall; Sara S McMillan; Fiona Kelly; Beth Hunter; Amanda J Wheeler Journal: Health Expect Date: 2013-01-31 Impact factor: 3.377
Authors: Rebekah J Walker; Brittany L Smalls; Jennifer A Campbell; Joni L Strom Williams; Leonard E Egede Journal: Endocrine Date: 2014-02-15 Impact factor: 3.633
Authors: Loes Jaspers; Veronica Colpani; Layal Chaker; Sven J van der Lee; Taulant Muka; David Imo; Shanthi Mendis; Rajiv Chowdhury; Wichor M Bramer; Abby Falla; Raha Pazoki; Oscar H Franco Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082